Scott Robarge is an experienced recruitment professional with more than a decade of experience in the industry. In 2010, he founded Another8, a recruiting firm that specializes in partnering with early to mid-stage technology companies. Outside of his professional pursuits, Scott Robarge focuses his philanthropic efforts toward supporting the Alzheimer’s Association.
The Alzheimer’s Association recently announced $2.2 million in funding for its Sex and Gender in Alzheimer’s (SAGA) initiative that will be distributed to nine studies aimed at understanding why women are disproportionately affected by Alzheimer’s disease.
There are approximately 5 million Americans that suffer from Alzheimer’s, with more than two-thirds of that number being women. According to recent data gathered by the Alzheimer’s Association, in adults over the age of 71, there is a 16 percent rate of the disease, but only an 11 percent rate among men.
While there are some working theories as to why women suffer more than men from Alzheimer’s, researchers still have no definitive answers. The Alzheimer’s Association hopes that, through funding research projects, more knowledge about the gender disparity will be gained.
In 2010, Scott Robarge founded Another8, a recruiting consultancy that helps meet the talent-acquisition goals of early- to mid-stage technology companies. Outside of his professional achievements, Scott Robarge is an active supporter of charitable organizations, and donates to the Alzheimer’s Association, the country’s premier voluntary health organization in Alzheimer’s care, support and research.
The Alzhemer’s Association recently announced that it is investing $7 million to support clinical trials that will target brain inflammation as a factor in developing Alzheimer’s disease therapy. The investment was made in partnership with a fundraising initiative called “Part the Cloud Challenge on Neuroinflammation,” led by Michaela “Mikey” Hoag, a philanthropist from Atherton, California. The fundraising drive aims to address a critical gap in the understanding and treatment of Alzheimer’s disease. After her father died from Alzheimer’s and her mother began showing symptoms, Hoag decided to launch the initiative in order to raise awareness and advance studies in drug development that might otherwise be hampered by lack of funding.